Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIK | AMGN | BMY | GILD | VRTX |
| Company | Anika Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 25.80 | 273.45 | 47.39 | 67.47 | 402.44 |
| High | 25.86 | 274.35 | 47.50 | 67.90 | 403.88 |
| Low | 25.49 | 267.24 | 44.61 | 65.32 | 393.00 |
| Last | 25.62 | 268.99 | 44.68 | 65.55 | 398.71 |
| Change | -0.28 | -4.02 | -4.18 | -1.53 | -2.05 |
| % Change | -1.08% | -1.47% | -8.56% | -2.28% | -0.51% |
| Volume | 14,475 | 613,073 | 24,258,904 | 4,608,149 | 335,950 |
| 20-Day Average Volume | 58,692 | 2,088,112 | 11,736,444 | 6,314,005 | 939,187 |
| Previous Close | 25.90 | 273.01 | 48.86 | 67.08 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.69 | 270.64 | 49.96 | 68.70 | 402.24 |
| 20-Day Raw Stochastic | 32.82% | 26.34% | 4.33% | 2.22% | 17.26% |
| 20-Day Relative Strength | 51.50% | 43.66% | 29.17% | 28.87% | 41.75% |
| Weighted Alpha | +8.11 | +8.36 | -33.92 | -23.34 | +14.29 |
| Today's Opinion | 80% Buy | 72% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 96% Buy | 40% Sell | 88% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 80% Buy | 24% Buy | 8% Sell | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.43% since 04/18/24 | +2.01% since 04/18/24 | -6.64% since 04/18/24 | -0.98% since 04/18/24 | +0.71% since 04/18/24 |
| Low | 25.45 on 04/19/24 | 260.68 on 04/19/24 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 391.25 on 04/19/24 |
| High | 26.16 on 04/23/24 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.78 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | +1.79% since 03/25/24 | -4.56% since 03/25/24 | -13.69% since 03/25/24 | -9.74% since 03/25/24 | -4.75% since 03/25/24 |
| Low | 24.90 on 04/12/24 | 260.68 on 04/19/24 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 391.01 on 04/18/24 |
| High | 26.85 on 04/04/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +5.67% since 01/25/24 | -13.61% since 01/25/24 | -9.10% since 01/25/24 | -18.35% since 01/25/24 | -7.84% since 01/25/24 |
| Low | 21.00 on 03/14/24 | 260.68 on 04/19/24 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 391.01 on 04/18/24 |
| High | 27.31 on 03/06/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +36.21% since 10/25/23 | -1.52% since 10/25/23 | -20.34% since 10/25/23 | -16.43% since 10/25/23 | +9.15% since 10/25/23 |
| Low | 18.44 on 10/27/23 | 249.70 on 10/31/23 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 341.90 on 11/16/23 |
| High | 27.31 on 03/06/24 | 329.72 on 02/05/24 | 55.29 on 10/26/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 384,615 | 146,436,016 | 99,027,448 | 83,519,768 | 103,580,040 |
| Shares Outstanding, K | 14,850 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 166,660,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -82,670,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 42,970,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -63,000,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 0.76 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -4.30 on 03/13/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 6.53 | 9.97 | 30.13 |